CompletedPHASE2, PHASE3NCT00974766

Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Principal Investigator
Ritesh Agarwal, MD, DM
Postgraduate Institute of Medical Education and Research, Chandigarh, India
Intervention
Glucocorticoids(drug)
Enrollment
92 enrolled
Eligibility
All sexes
Timeline
20092011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00974766 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials